Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Wegener

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Molecular Genetics and Metabolism|October 22, 2003
Recent progress in the development of assays suited for histone deacetylase inhibitor screeningDennis Wegener, Christian Hildmann, Andreas Schwienhorst
Studies in Health Technology and Informatics|July 14, 2009
Workflows for intelligent monitoring using proxy servicesStefan Rüping, Dennis Wegener, Stelios Sfakianakis, et al.
Chemistry & Biology|February 8, 2003
A fluorogenic histone deacetylase assay well suited for high-throughput activity screeningDennis Wegener, Frank Wirsching, Daniel Riester, et al.
Biochemical and Biophysical Research Communications|October 16, 2004
Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substratesDaniel Riester, Dennis Wegener, Christian Hildmann, et al.
Analytical Biochemistry|September 27, 2003
Improved fluorogenic histone deacetylase assay for high-throughput-screening applicationsDennis Wegener, Christian Hildmann, Daniel Riester, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|April 3, 2007
Complex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitorTine Kragh Nielsen, Christian Hildmann, Daniel Riester, et al.
The Biochemical Journal|October 14, 2006
An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzymeKristin Moreth, Daniel Riester, Christian Hildmann, et al.
Anti-Cancer Drugs|September 4, 2008
HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cellsDennis Wegener, Hedwig E Deubzer, Ina Oehme, et al.
Journal of Bacteriology|April 3, 2004
A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylasesChristian Hildmann, Milena Ninkovic, Rüdiger Dietrich, et al.
Journal of Biotechnology|March 29, 2006
Substrate and inhibitor specificity of class 1 and class 2 histone deacetylasesChristian Hildmann, Dennis Wegener, Daniel Riester, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecular Genetics and Metabolism|October 22, 2003
Recent progress in the development of assays suited for histone deacetylase inhibitor screeningDennis Wegener, Christian Hildmann, Andreas Schwienhorst
Studies in Health Technology and Informatics|July 14, 2009
Workflows for intelligent monitoring using proxy servicesStefan Rüping, Dennis Wegener, Stelios Sfakianakis, et al.
Chemistry & Biology|February 8, 2003
A fluorogenic histone deacetylase assay well suited for high-throughput activity screeningDennis Wegener, Frank Wirsching, Daniel Riester, et al.
Biochemical and Biophysical Research Communications|October 16, 2004
Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substratesDaniel Riester, Dennis Wegener, Christian Hildmann, et al.
Analytical Biochemistry|September 27, 2003
Improved fluorogenic histone deacetylase assay for high-throughput-screening applicationsDennis Wegener, Christian Hildmann, Daniel Riester, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|April 3, 2007
Complex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitorTine Kragh Nielsen, Christian Hildmann, Daniel Riester, et al.
The Biochemical Journal|October 14, 2006
An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzymeKristin Moreth, Daniel Riester, Christian Hildmann, et al.
Anti-Cancer Drugs|September 4, 2008
HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cellsDennis Wegener, Hedwig E Deubzer, Ina Oehme, et al.
Journal of Bacteriology|April 3, 2004
A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylasesChristian Hildmann, Milena Ninkovic, Rüdiger Dietrich, et al.
Journal of Biotechnology|March 29, 2006
Substrate and inhibitor specificity of class 1 and class 2 histone deacetylasesChristian Hildmann, Dennis Wegener, Daniel Riester, et al.
Pageof 2